Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Statement on Most Favored Nation
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…
Learn more
BIO Statement on Industry Tariffs
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…
Learn more
BIO Extends Agreement with Avantor for Five…
Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO’s Dr. McMurry-Heath Calls on HHS Sec. Azar to Publicly Release FDA Guidance on Emergency Use Authorization for Covid-19 Vaccines
October 2, 2020
Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO), released a letter today urging Health and Human Services (HHS) Secretary Alex Azar to “publicly release all new guidance developed by the Food and…
North Carolina Governor Roy Cooper Named BIO’s Governor of the Year
October 2, 2020
BIO recognizes Governor Cooper’s leadership in biotechnology & innovation Today, the Biotechnology Innovation Organization awarded Roy Cooper, Governor of North Carolina, with its 2020 Governor of the Year Award. Governor Cooper was presented…
Gov. Hogan, Novavax’ Erck, & BIO’s Dr. McMurry-Heath Toured Novavax Labs and Discussed Progress on COVID-19 Vaccine
September 24, 2020
Event Highlighted Leadership in Vaccine Development and Regional Growth in Biotechnology Innovation Gaithersburg, MD (September 24, 2020) – Today, Maryland Governor Larry Hogan and Dr. Michelle McMurry-Heath, President & CEO of Biotechnology…
BIO Presents Leadership and Legacy Award to Sharon Bomer Lauritsen
September 22, 2020
Washington, D.C. (September 22, 2020) –The Biotechnology Innovation Organization (BIO) today presented Sharon Bomer Lauritsen, founder of AgTrade Strategies LLC, former Assistant United States Trade Representative for Agricultural Affairs and…
BIO Announces 2020 BIO IMPACT Award Winners
September 18, 2020
Washington, D.C. (September 17, 2020) – The Biotechnology Innovation Organization (BIO) announced Dr. Pramod Chaudhari, Executive Chairman of Praj Industries Limited, as the winner of the 2020 George Washington Carver Award for Innovation in…
Senator Stabenow, BIO CEO, and Industry Leaders to Convene BIO IMPACT “Justice Through Science” Plenary
September 15, 2020
Washington, D.C. (September 15, 2020) – Next week at BIO IMPACT Digital (Sept. 21-22), Sen. Debbie Stabenow (D-MI) will join a panel of women leaders in the bioeconomy for a timely discussion about how smart policy can drive scientific …
BIO’s Dr. McMurry-Heath Says Adopting Foreign Price Controls a “Reckless Scheme” that will “Eliminate Hope for Vulnerable Seniors”
September 13, 2020
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose foreign price controls on medicines covered under…
USDA Secretary Headlines First-Ever BIO IMPACT Ag & Environment Digital Conference
September 9, 2020
Washington, D.C. (September 9, 2020) – U.S. Agriculture (USDA) Secretary Sonny Perdue will join leaders across the bioeconomy—in agriculture, sustainable fuels, and biobased manufacturing— for discussions on the role of biotechnology in protecting…
Biotech Leaders Outline Principles to Ensure the “Public’s Trust” in New Medical Products for Eradicating Covid-19
September 3, 2020
As America’s researchers race to develop the scientific solutions needed to eradicate Covid-19, leaders within the Biotechnology Innovation Organization (BIO) released an open letter to their biopharmaceutical colleagues that articulates key…
New CMS Reimbursement Rule “Reaffirms the Many Benefits of Transformational Therapies”
September 2, 2020
Today, the Centers for Medicare and Medicaid Services finalized this year’s inpatient prospective payment system (IPPS) rule, which includes a new diagnosis-related group (DRG) to streamline reimbursements for providers administering CAR T-cell…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today